Real-World Effectiveness of Bevacizumab Based on AURELIA in Platinum-resistant Recurrent Ovarian Cancer

计划入组 50 人 · 首次发布于 2017 年 12 月 8 日

AURELIA: A Study of Avastin (Bevacizumab) Added to Chemotherapy in Patients With Platinum-resistant Ovarian Cancer

计划入组 361 人 · 首次发布于 2009 年 9 月 15 日

Clinical Trial Comparing Safety and Pharmacokinetics of Standard Antibiotic Therapy, Plus Aurexis® or Placebo, for Treatment of Staphylococcus Aureus Bacteremia (SAB)

计划入组 60 人 · 首次发布于 2005 年 9 月 20 日

small molecule analogs (Acretia)

tryptophanase inhibitor (uremia/ late stage chronic kidney disease)

VLA-4/VCAM-1 inhibitors (University of the Basque Country)

HEALTH FOUNDRY PTY LTD

Australia

United Microelectronics

ACM Research

United States

LambdaVision Secures $7M Seed Funding to Advance Space-Manufactured Artificial Retina for Blindness Treatment

Penn Launches $18 Million AI-Driven RNA Foundry to Democratize mRNA Technology Beyond Vaccines

Pathos AI Acquires Majority Stake in DeuterOncology to Advance AI-Identified MET Inhibitor DO-2